Industries > Pharma > Biobanking Market Report 2024-2034
Back to Pharma Reports
Biobanking Market Report 2024-2034

Biobanking Market Report 2024-2034

Forecasts by Ownership (National/Regional Agencies, Universities, Non-profit, Private), by Product and Service (Equipment, Consumables, Services, Software), by Sample (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Others), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by End-users (Pharmaceutical & Biotechnology Companies, CROs, Academic & Research Institutes, Hospitals) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis

PUBLISHED: 19 February 2024
PAGES: 264
PRODUCT CODE: PHA1317
SUBMARKET: Biotechnology Next Generation Technologies

WOOCS 2.2.1
DOWNLOAD FREE SAMPLE
SKU: PHA1317 Categories: , , Tags: ,

The Biobanking Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Growing Investments and Funding Projected to Boost Industry Growth

Biobanks are experiencing increased acknowledgment and support from global governments, research bodies, and financial institutions, leading to a surge in investment in these facilities. Notably, initiatives like the Biorepository and Precision Medicine Initiative Cohort Program, funded by the U.S. National Institutes of Health (NIH), seek to amass biological samples from over a million individuals to establish a comprehensive national research resource. Concurrently, the European Commission has committed funding to the Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), a pan-European facility focused on biobanking and biomolecular resources. This heightened attention and financial backing underscore the strategic importance of biobanks in advancing scientific research and precision medicine on a global scale.

Hight Cost of Equipment Likely to Challenge Industry Growth

The market’s growth potential is anticipated to face limitations due to the substantial expenses associated with automated equipment. While cutting-edge technologies like advanced sample handling systems have the potential to enhance operational efficiency and elevate the quality of biobanking processes, their high price tags pose a considerable challenge, particularly for smaller biobanking enterprises or those with constrained financial capacities. Take, for instance, the expenditure involved in acquiring an automated storage system, which can vary based on its size and complexity. The initial capital outlay for such systems can be substantial, ranging from tens of thousands to hundreds of thousands of dollars. Beyond the initial investment, ongoing considerations encompass maintenance and operational expenses, including software updates, repairs, and training. This cost factor serves as a strategic consideration for businesses evaluating the incorporation of automated equipment in their biobanking operations.

What Questions Should You Ask before Buying a Market Research Report?
  • How is the biobanking market evolving?
  • What is driving and restraining the biobanking market?
  • How will each biobanking submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each biobanking submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading biobanking markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the biobanking projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of
    biobanking projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the biobanking market?
  • Where is the biobanking market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the biobanking market today, and over the next 10 years:
  • Our 264-page report provides 121 tables and 182 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them – NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the biobanking market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2034 and other analyses reveal commercial prospects
  • In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, PEST Analysis and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.

Segments Covered in the Report
Ownership
  • National/Regional Agencies
  • Universities
  • Non-profit
  • Private
Product and Service
  • Equipment
  • Consumables
  • Services
  • Software
Sample
  • Blood Products
  • Human Tissues
  • Nucleic Acids
  • Cell Lines
  • Biological Fluids
  • Others
Application
  • Regenerative Medicine
  • Life Science Research
  • Clinical Research
End-users
  • Pharmaceutical & Biotechnology Companies
  • CROs
  • Academic & Research Institutes
  • Hospitals

CTA

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 22 leading national markets:

North America
  • U.S.
  • Canada
Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific
Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
MEA
  • GCC
  • South Africa
  • Rest of MEA

Biobanking Market Report 2024-2034
Need industry data? Please contact us today.

The report also includes profiles and for some of the leading companies in the Biobanking Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report
  • ASKION GmbH
  • Avantor Inc.
  • Azenta Inc.
  • Boca Biolistics
  • BIOIVT & ELEVATING SCIENCE
  • Cryoport Inc.
  • CTI Biotech
  • Hamilton Company
  • Isenet Biobanking
  • Merck & Co., Inc.
  • PHC Holdings Corporation
  • ProteoGenex Inc.
  • Qiagen N.V.
  • Thermo Fisher Scientific, Inc.
  • Tecan Trading AG
  • US Biolab Corp. Inc.

Overall world revenue for Biobanking Market, 2024 to 2034 in terms of value the market will surpass US$75.0 billion in 2024, our work calculates. We predict strong revenue growth through to 2034. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Biobanking Market, 2024 to 2034 report help you?

In summary, our 260+ page report provides you with the following knowledge:

  • Revenue forecasts to 2034 for Biobanking Market 2024 to 2034, with forecasts for ownership, product and service, sample, application, end-users each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 22 key national markets – See forecasts for the Biobanking Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market – including company profiles for 16 of the major companies involved in the Biobanking Market, 2024 to 2034.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Biobanking Market 2024 to 2034, market-leading companies. You will find data, trends and predictions.

To access the data contained in this document please email contactus@visiongain.com

Buy our report today Biobanking Market Report 2024-2034: Forecasts by Ownership (National/Regional Agencies, Universities, Non-profit, Private), by Product and Service (Equipment, Consumables, Services, Software), by Sample (Blood Products, Human Tissues, Nucleic Acids, Cell Lines, Biological Fluids, Others), by Application (Regenerative Medicine, Life Science Research, Clinical Research), by End-users (Pharmaceutical & Biotechnology Companies, CROs, Academic & Research Institutes, Hospitals) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biobanking Market Report 2024-2034

    Related reports

    Download sample pages

    Complete the form below to download your free sample pages for Biobanking Market Report 2024-2034

      Connect with us

      Visiongain Pharma

      Visiongain Pharma

      Visiongain Pharma

      Latest Pharma news

      Visiongain Publishes Peripheral Vascular Device Market Report 2024-2034

      The global Peripheral Vascular Devices market is estimated at US$12.49 billion in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period 2024-2034.

      30 April 2024

      READ
      Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034

      The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.

      23 April 2024

      READ
      Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034

      The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.

      18 April 2024

      READ
      Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034

      The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.

      17 April 2024

      READ